Regulation of Cell Proliferation and Migration by miR-203 via GAS41/miR-10b Axis in Human Glioblastoma Cells.

by Dhananjaya Pal, Debasmita Mukhopadhyay, M Janaki Ramaiah, Pranjal Sarma, Utpal Bhadra, Manika Pal Bhadra
Published 2016-01-01

Combinatorial inhibition of BTK, PI3K-AKT and BRD4-MYC as a strategy for treatment of mantle cell lymphoma

by Kendra R. Vann, Dhananjaya Pal, Audrey L. Smith, Namood-e Sahar, Maddeboina Krishnaiah, Dalia El-Gamal, Tatiana G. Kutateladze
Published 2022-01-01

The BTK/PI3K/BRD4 axis inhibitor SRX3262 overcomes Ibrutinib resistance in mantle cell lymphoma

by Dhananjaya Pal, Kendra R. Vann, Shweta Joshi, Namood E. Sahar, Guillermo A. Morales, Dalia El-Gamal, Tatiana G. Kutateladze, Donald L. Durden
Published 2021-09-01

Selective killing of homologous recombination-deficient cancer cell lines by inhibitors of the RPA:RAD52 protein-protein interaction.

by Mona Al-Mugotir, Jeffrey J Lovelace, Joseph George, Mika Bessho, Dhananjaya Pal, Lucas Struble, Carol Kolar, Sandeep Rana, Amarnath Natarajan, Tadayoshi Bessho, Gloria E O Borgstahl
Published 2021-01-01

1425 The novel small molecule multitarget inhibitor LCI133 sensitizes endometrial carcinoma to TRAIL-mediated apoptosis

by Erin Crane, Jubilee Brown, Cody C McHale, Ritchie Delara, Dhananjaya Pal, Krishnaiah Maddeboina, Hailey Dryden, Page Mangum Arditti, Bharath Yada, R Wendel Naumnn, Donald Durden
Published 2023-11-01

Preclinical Evaluation of a Novel Dual Targeting PI3Kδ/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic Leukemia

by Yongsheng Ruan, Yongsheng Ruan, Hye Na Kim, Heather A. Ogana, Zesheng Wan, Samantha Hurwitz, Cydney Nichols, Nour Abdel-Azim, Ariana Coba, Seyoung Seo, Yong-Hwee Eddie Loh, Eun Ji Gang, Hisham Abdel-Azim, Chih-Lin Hsieh, Michael R. Lieber, Chintan Parekh, Dhananjaya Pal, Deepa Bhojwani, Donald L. Durden, Donald L. Durden, Yong-Mi Kim
Published 2021-12-01